Dx firms AutoGenomics and Singulex try their luck in public markets
This article was originally published in Clinica
Executive Summary
Two Californian diagnostics firms are taking a chance on the sluggish initial public offering market: AutoGenomics and Singulex are looking to raise $65 million and $86 million, respectively.